FDA Drug Application (021520) for SYMBYAX by LILLY

Back to FDA Applications sponsored by LILLY

Application Number021520
Product Number001
FormCAPSULE;ORAL
DosageEQ 25MG BASE;EQ 3MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameSYMBYAX
Active IngredientFLUOXETINE HYDROCHLORIDE; OLANZAPINE

Active IngredientCount
List of drugs with Active Ingredient FLUOXETINE HYDROCHLORIDE8
List of drugs with Active Ingredient OLANZAPINE5


Back to FDA Applications sponsored by LILLY